PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.670
+0.180 (12.08%)
Jan 22, 2025, 12:52 PM EST - Market open
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $62.47 million as of January 22, 2025. Its market cap has decreased by -60.71% in one year.
Market Cap
62.47M
Enterprise Value
33.58M
1-Year Change
-60.71%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since October 1, 2015, PDS Biotechnology's market cap has decreased from $334.50M to $62.47M, a decrease of -81.32%. That is a compound annual growth rate of -16.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 55.70M | -8.69% |
| Dec 31, 2024 | 61.00M | -60.54% |
| Dec 29, 2023 | 154.60M | -58.92% |
| Dec 30, 2022 | 376.30M | 63.40% |
| Dec 31, 2021 | 230.30M | 383.82% |
| Dec 31, 2020 | 47.60M | 211.11% |
| Dec 31, 2019 | 15.30M | 51.49% |
| Dec 31, 2018 | 10.10M | -96.51% |
| Dec 29, 2017 | 289.20M | -20.00% |
| Dec 30, 2016 | 361.50M | 0.39% |
| Dec 31, 2015 | 360.10M | 7.65% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.47B |
| UnitedHealth Group | 480.75B |
| Novo Nordisk | 355.54B |
| Johnson & Johnson | 345.06B |
| AbbVie | 299.87B |
| Merck & Co. | 242.33B |
| Thermo Fisher Scientific | 220.40B |
| Intuitive Surgical | 218.17B |